First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
Clinical trial NCT01524991 · COMPLETED
Trial details
- NCT number
- NCT01524991
- Sponsor
- Hoosier Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2017-07-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.